BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1912513)

  • 1. The role of MHC class I expression in developmental tumours.
    Stern PL; Rinke de Wit TF
    Semin Cancer Biol; 1991 Feb; 2(1):11-6. PubMed ID: 1912513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines.
    Rinke de Wit TF; Vloemans S; van den Elsen PJ; Haworth A; Stern PL
    J Immunol; 1990 Feb; 144(3):1080-7. PubMed ID: 2104910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].
    Zhang C; Tian Z; Hou G
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):369-72. PubMed ID: 11810763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface expression of HLA-C antigen by human extravillous trophoblast.
    King A; Burrows TD; Hiby SE; Bowen JM; Joseph S; Verma S; Lim PB; Gardner L; Le Bouteiller P; Ziegler A; Uchanska-Ziegler B; Loke YW
    Placenta; 2000 May; 21(4):376-87. PubMed ID: 10833373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells.
    Zdravkovic M; Aboagye-Mathiesen G; Guimond MJ; Hager H; Ebbesen P; Lala PK
    Placenta; 1999; 20(5-6):431-40. PubMed ID: 10419808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel human MHC class I genes are expressed by tumour cell lines representing embryonic and extraembryonic tissues.
    Rinke de Wit TF; Vloemans AA; van den Elsen PJ; Ward J; Sutcliffe RC; Glazebrook J; Haworth A; Stern PL
    J Immunogenet; 1989; 16(4-5):391-6. PubMed ID: 2639910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted.
    Poláková K; Russ G
    Neoplasma; 2000; 47(6):342-8. PubMed ID: 11263857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar.
    Anderson DJ; Berkowitz RS
    J Immunol; 1985 Oct; 135(4):2498-501. PubMed ID: 3928751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
    Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
    J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
    Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
    Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?
    Schrier PI; Versteeg R; Peltenburg LT; Plomp AC; van 't Veer LJ; Krüse-Wolters KM
    Semin Cancer Biol; 1991 Feb; 2(1):73-83. PubMed ID: 1912519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
    Fletcher JM; Prentice HG; Grundy JE
    J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal trophoblasts resist induction of class I HLA.
    Hunt JS; Andrews GK; Wood GW
    J Immunol; 1987 Apr; 138(8):2481-7. PubMed ID: 3104468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells.
    Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H
    J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune recognition of HLA-G-expressing choriocarcinoma cell line Jeg-3.
    Burt D; Johnston D; Rinke de Wit T; Van den Elsen P; Stern PL
    Int J Cancer Suppl; 1991; 6():117-22. PubMed ID: 2066177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
    Ballardini G; Groff P; Pontisso P; Giostra F; Francesconi R; Lenzi M; Zauli D; Alberti A; Bianchi FB
    J Clin Invest; 1995 May; 95(5):2067-75. PubMed ID: 7738174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.